DCT

1:23-cv-00266

Neurocrine Biosciences Inc v. Zydus Pharma USA Inc

General
Filed
03/10/23
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
45%